Literature DB >> 17974155

Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients.

Ghada Mohamed El-Sayed1, Waleed Seif El-din Mohamed, Mohamed Akram Nouh, Manar Mohamed Moneer, Hadir Ahmed El-Mahallawy.   

Abstract

Several studies have suggested an association between Hepatitis C and B viruses (HCV and HBV) and non-Hodgkin's lymphoma (NHL). In the present study we have searched for viral genomes and antigens in the malignant lymphoma tissues as well as their seroprevalence. Antibodies against Hepatitis C as well as HCV RNA and hepatitis B surface antigen (HBsAg) were determined for 29 newly diagnosed non-Hodgkin's lymphoma patients using an enzyme linked immunosorbent assay (ELISA), as well as RT-PCR and compared with 36 apparently healthy individuals as a control group for viral markers. Immunohistochemical staining (IHC) was performed on paraffin embedded tissues for the NS3 of HCV and for HBsAg of HBV using the immunoperoxidase technique. Paraffin embedded lymph nodes (LN) were studied for the presence of viral sequences. Ten non-metastatic lymph nodes (LN) from cancer cases other than NHL were used as a control for IHC and molecular studies. HCV was significantly more encountered in patients with NHL when compared to controls for both antibodies (27.6% versus 8.3% of serum controls; p = 0.04), and antigens studied by IHC in the involved LN (41% versus 10% of tissue controls; p = 0.06). Although HBsAg positivity was not different in NHL patients when compared to controls (6.9% and 2.7%); yet it was significantly more encountered in LN of NHL patients (p = 0.04). HBV-DNA was detected in 27.5% of patient's samples and none of the controls. In conclusion, overall our findings confirm the presence of HBV and HCV antigens and viral sequences in the involved LNs of NHL patients, except for HCV RNA which perhaps necessitates fresh and not paraffin embedded tissues. These results strengthen the assumption that these viruses may be involved in the development of NHL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17974155

Source DB:  PubMed          Journal:  Egypt J Immunol


  10 in total

1.  Immunohistochemical detection of hepatitis C virus (genotype 4) in B-cell NHL in an Egyptian population: correlation with serum HCV-RNA.

Authors:  Iman Gouda; Ola Nada; Sameera Ezzat; Mai Eldaly; Christopher Loffredo; Clive Taylor; Mohamed Abdel-Hamid
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-01

2.  B-cell clonality in the liver of hepatitis C virus-infected patients.

Authors:  He-Bin Fan; You-Fu Zhu; An-Shen Chen; Mu-Xiu Zhou; Fu-Ming Yan; Xiao-Ju Ma; Hao Zhou
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

3.  Association of risk of non-Hodgkin's lymphoma with hepatitis B virus infection: a meta-analysis.

Authors:  Zhenjia Qi; Hao Wang; Guangxun Gao
Journal:  Int J Clin Exp Med       Date:  2015-12-15

Review 4.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Authors:  Yousra A Mohamoud; Ghina R Mumtaz; Suzanne Riome; Dewolfe Miller; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2013-06-24       Impact factor: 3.090

5.  HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma.

Authors:  Xinying Zhao; Xudong Guo; Libo Xing; Wenqin Yue; Haisen Yin; Miaoxia He; Jianmin Wang; Jianmin Yang; Jie Chen
Journal:  Cell Death Dis       Date:  2018-01-19       Impact factor: 8.469

6.  Pro-oncogenic, intra host viral quasispecies in Diffuse large B cell lymphoma patients with occult Hepatitis B Virus infection.

Authors:  Mahua Sinha; Keerthana Sundar; C S Premalata; Vikas Asati; Alka Murali; Akhilesh Kumar Bajpai; Sravanthi Davuluri; Kshitish K Acharya; K C Lakshmaiah; Govind Babu K; Linu A Jacob; Dharam Nandan; Dinesh Velayutham; Sibnarayan Datta; R S Jayshree
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

7.  lncNBAT1/APOBEC3A is a mediator of HBX-induced chemoresistance in diffuse large B cell lymphoma cells.

Authors:  Jianguo Li; Yaqi Chen; Xuecong Guo; Xiaofei Bai; Xu Xu; Tong Han; Ailing Tan; Nana Liu; Yuchen Xia; Qiaoyi Sun; Xudong Guo; Jie Chen; Jiuhong Kang
Journal:  Mol Ther Nucleic Acids       Date:  2022-01-25       Impact factor: 8.886

8.  Prevalence of occult hepatitis C virus in egyptian patients with chronic lymphoproliferative disorders.

Authors:  Samar Samir Youssef; Aml S Nasr; Taher El Zanaty; Rasha Sayed El Rawi; Mervat M Mattar
Journal:  Hepat Res Treat       Date:  2012-12-12

9.  Plasma Epstein-Barr virus and Hepatitis B virus in non-Hodgkin lymphomas: Two lymphotropic, potentially oncogenic, latently occurring DNA viruses.

Authors:  Mahua Sinha; Clementina Rama Rao; C S Premalata; Mohammed Shafiulla; K C Lakshmaiah; Linu Abraham Jacob; Govind K Babu; B K Viveka; L Appaji; Jayshree R Subramanyam
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Jul-Sep

10.  [Analysis of HBV, HCV and EBV infections in diffuse large B cell lymphoma].

Authors:  X J Wu; C G Xu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-09-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.